The Relationship of Headache with Inflammatory Serum Parameters and Disease Severity in COVID-19 Patients
dc.contributor.author | Alay, Handan | |
dc.contributor.author | Bilge, Nuray | |
dc.contributor.author | Can, Fatma Kesmes | |
dc.date.accessioned | 2023-04-10T20:19:33Z | |
dc.date.available | 2023-04-10T20:19:33Z | |
dc.date.issued | 2020 | |
dc.department | Rektörlük, Rektörlüğe Bağlı Birimler, Düzce Üniversitesi Dergileri | en_US |
dc.description.abstract | Aim: Most of the coronavirus disease 2019 (COVID-19) patients have respiratory symptoms;however, various neurological symptoms, such as headache, can be seen. Thepathophysiological mechanism of headache in COVID-19 is unknown completely. In ourstudy, we aimed to investigate the relationship between headache and inflammatory markersand disease severity in COVID-19 patients.Material and Methods: Two hundred and three hospitalized patients with a polymerase chainreaction (PCR)-confirmed COVID-19 diagnosis between 15 March and 01 June 2020 wereretrospectively investigated. A total of 62 patients with headache symptoms (n=31) andwithout headache symptoms (n=31), who were age and gender-matched, were included in thestudy. The demographic characteristics, inflammatory serum parameters,neutrophil/lymphocyte ratio (NLR), C-reactive protein (CRP)/albumin ratio (CAR),hospitalization times, and disease severity were determined.Results: Of the 203 COVID-19 patients, 36 (17.7%) had a headache, and it was the fourthmost common symptom. Headache accompanied other symptoms in all patients. Of thepatients with headache, 14 (45.2%) were female, 17 (54.8%) were male, and the mean age was37.74±16.65 years. In our COVID-19 patients, the neutrophil count, NLR, CRP, CAR weresignificantly higher, and hospital stay was longer in patients with headache than those withoutheadache (p=0.023, p=0.041, p=0.034, p=0,048 and p=0.049, respectively).Conclusion: As a result, the increased inflammatory response may play a role in thepathogenesis of headache in COVID-19 patients. Our study is the first study that evaluated therelationship between headache symptom and inflammation in COVID-19 patients. Furtherresearch is needed on this subject. | en_US |
dc.identifier.doi | 10.18678/dtfd.776731 | |
dc.identifier.endpage | 50 | en_US |
dc.identifier.issn | 1307-671X | |
dc.identifier.issue | S1 | en_US |
dc.identifier.startpage | 44 | en_US |
dc.identifier.trdizinid | 386555 | en_US |
dc.identifier.uri | http://doi.org/10.18678/dtfd.776731 | |
dc.identifier.uri | https://search.trdizin.gov.tr/yayin/detay/386555 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12684/11409 | |
dc.identifier.volume | 22 | en_US |
dc.indekslendigikaynak | TR-Dizin | en_US |
dc.language.iso | en | en_US |
dc.relation.ispartof | Düzce Tıp Fakültesi Dergisi | |
dc.relation.publicationcategory | Makale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.title | The Relationship of Headache with Inflammatory Serum Parameters and Disease Severity in COVID-19 Patients | en_US |
dc.type | Article | en_US |
Dosyalar
Orijinal paket
1 - 1 / 1
Yükleniyor...
- İsim:
- 11409.pdf
- Boyut:
- 408.53 KB
- Biçim:
- Adobe Portable Document Format
- Açıklama:
- Tam Metin / Full Text